Semax Dosage and Protocols
Semax dosage protocols reported in published research, plus reconstitution and storage.
Research Protocol Doses Reported in Published Literature
Research Disclaimer: Doses reported below are from published preclinical research protocols. Semax is not approved for human use by the FDA or any regulatory agency. This information is provided for research reference only and does not constitute a dosing recommendation. All doses above are reported from published research protocols using laboratory subjects. Refer to the cited studies in the Research Studies section above for original source data.
Reported protocol doses
Reconstitution
A 10mg vial with 2mL of bacteriostatic water is the pairing reported most often. Often supplied as a nasal solution. As a 10mg vial + 2mL = 5000mcg/mL, a 300mcg dose is ~3 drops depending on dropper calibration.
Work out your own concentration with the reconstitution calculator.
Doses shown are those reported in published research, not a recommendation.
References
- Semax, an ACTH(4-10) analogue, and brain BDNF expression · Dolotov OV, et al. · 2006
- Dergunova LV, Filippenkov IB, Stavchansky VV, et al. Novel insights into the protective properties of ACTH(4-7)PGP (Semax) peptide at the transcriptome level following cerebral ischaemia-reperfusion in rats. Genes (Basel). 2020;11(6):681. · Filippenkov IB, Stavchansky VV, Denisova AE, Yuzhakov VV, Sevan'kaeva LE, Sudarkina OY, Dmitrieva VG, Gubsky LV, Myasoedov NF, Limborska SA, Dergunova LV · 2020
- [Results of the application of complex physiotherapeutic neurostimulation in optical neuropathies of various genesis]. · Dragon AK, Korchazhkina NB, Sheludchenko VM et al. · 2022
- The peptide semax affects the expression of genes related to the ... · Medvedeva EV, Dmitrieva VG, Povarova OV, Limborska SA, Skvortsova VI, Myasoedov NF, Dergunova LV · 2014
- Functional Connectomic Approach to Studying Selank and Semax Effects. · Panikratova YR, Lebedeva IS, Sokolov OY et al. · 2020
- [Evaluation of therapeutic effect of new Russian drug semax in optic ... · Polunin GS, Nurieva SM, Baiandin DL, Sheremet NL, Andreeva LA · 2000